StockTipsArenaBeta

BUY Alkem Laboratories Limited — Prakash Gaba

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via CNBC Awaaz.

Entry₹5,378.5Inferred
Target₹5,400
Total upside +0.40% (call closed)
Stop loss₹5,300-1.46% risk
Exit₹5,40018 Sept 2026, 3:30 pm
Target hit+0.40%0.00%upside left
Follow Prakash Gaba for new calls(32% target hit, 322 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 1 active Swing call on ALKEMSee 203 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

Alkem Laboratories Limited has launched NeuCeno (cenobamate) for treating partial-onset seizures in adult patients.

BSE · Company Update·16 Sept · 2d ago

(opens in new tab)

Alkem Laboratories has launched Renocia ExoTM, a hair growth serum based on patented Ginsenoside Exosomes, marking a significant product introduction in India.

BSE · Company Update·8 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from Prakash Gaba

Every call and its outcome